These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6921530)

  • 21. Radioimmunoassay of carcinoembryonic antigen and clinical significance of its level in plasma.
    Onizawa S; Watanabe S; Yagura T; Yasutomi M; Yamamura Y
    Gan; 1976 Jun; 67(3):371-8. PubMed ID: 1001864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Carcinoembryonic antigen in a review of cases in the literature].
    Troccoli R; Stella F; Stella C; Battistelli S; Antonioni M; Marcheggiani F; Mannello F; Biagioni S; Artico M; Terzano C
    Quad Sclavo Diagn; 1987 Sep; 23(3):233-45. PubMed ID: 3332377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experimental and clinical evaluations of Phadebas CEA PRIST kit].
    Chida R; Tsujino D; Shirakura H; Yomoda Y; Shimizu M; Fukushima M; Sasaki Y; Someya K
    Kaku Igaku; 1982 Jul; 19(6):975-82. PubMed ID: 7154415
    [No Abstract]   [Full Text] [Related]  

  • 24. CEA as a cancer marker.
    Consens Dev Conf Summ Natl Inst Health; 1980; 3():55-8. PubMed ID: 7023817
    [No Abstract]   [Full Text] [Related]  

  • 25. National Institutes of Health consensus development conference statement CEA (carcinoembryonic antigen): its role as a marker in the management of cancer.
    J Ark Med Soc; 1981 Jun; 78(1):65-8. PubMed ID: 6454681
    [No Abstract]   [Full Text] [Related]  

  • 26. Carcinoembryonic antigen: its role as a marker in the management of cancer. A National Institutes of Health Consensus Development Conference.
    Ann Intern Med; 1981 Mar; 94(3):407-9. PubMed ID: 7224393
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diagnostic value of 4 biological markers: lactate dehydrogenase, phosphoglucoisomerase, carcinoembryonic antigen and gammaglutamyl transpeptidase, systematically determined in patients in a hematology-oncology department].
    Taillan B; Barthelemy G; Routy JP; Pedinielli FJ; Zarrouk F; Chardon H; Blanc AP
    Pathol Biol (Paris); 1987 Apr; 35(4):375-80. PubMed ID: 2884616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Handling sera for tumour marker studies.
    Mitchell H
    Lancet; 1984 Oct; 2(8407):877. PubMed ID: 6207399
    [No Abstract]   [Full Text] [Related]  

  • 29. [Changes in carcinoembryonic antigen and tissue polypeptide antigen in monitoring the post-operative course of some tumor types].
    Ciaccio B; Caponi A; Cappetti P; Fanciullacci A; Bartoli P; Berti P
    Quad Sclavo Diagn; 1985 Jun; 21(2):199-205. PubMed ID: 4080962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tests for carcinoembryonic antigen. Role in diagnosis and management of cancer.
    Gold P; Freedman SO
    JAMA; 1975 Oct; 234(2):190-2. PubMed ID: 1242158
    [No Abstract]   [Full Text] [Related]  

  • 31. Cancer-associated plasma proteins and lymphocyte function in patients with carcinoma.
    Kasukawa R; Masaki M; Watanabe K; Ohara M; Murai T; Yoshida T
    Fukushima J Med Sci; 1977; 24(3-4):95-106. PubMed ID: 83956
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical applications of serum carcinoembryonic antigen and alpha-fetoprotein levels in children with solid tumours.
    Mann JR; Lakin GE; Leonard JC; Rawlinson HA; Richardson SG; Corkery JJ; Cameron AH; Shah KJ
    Arch Dis Child; 1978 May; 53(5):366-74. PubMed ID: 78685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma lipid-bound sialic acid and carcinoembryonic antigen in cancer patients.
    Dnistrian AM; Schwartz MK
    Clin Chem; 1981 Oct; 27(10):1737-9. PubMed ID: 7285326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A comparative evaluation of tumor markers (TPA and CEA) in various malignant neoplasms at an advanced stage].
    Meregalli M; Antoniazzi V; Torchio G; Colombo E; Bocchi M; Sonzini E; Lino S
    Minerva Med; 1989 Apr; 80(4):345-7. PubMed ID: 2725935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic significance of carcinoembryonic antigen (CEA) concentrations: --a study of 61 patients with malignancies--.
    Pick AI; Shoenfeld Y; Zelikovski A; Wolloch J; Mintz U
    Am J Proctol; 1977 Jun; 28(3):37-43. PubMed ID: 869021
    [No Abstract]   [Full Text] [Related]  

  • 36. [Fundamental study and clinical evaluation of radioimmunoassay of CEA using double antibody technique (author's transl)].
    Ishikawa N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1979 Feb; 39(2):120-31. PubMed ID: 450648
    [No Abstract]   [Full Text] [Related]  

  • 37. Carcinoembryonic antigen (CEA) in patients with malignant and non-malignant diseases.
    Alsabti EA; Kamel A
    Neoplasma; 1979; 26(5):603-9. PubMed ID: 230422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study of serum ferritin in malignant tumors. -- Significance as a tumor marker (author's transl)].
    Jibiki K; Demura H; Fukunaga T; Yamanaka Y; Hoshino Y
    Horumon To Rinsho; 1980 Sep; 28(9):1085-91. PubMed ID: 7460361
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical evaluation of urinary and serum carcinoembryonic antigen in bladder cancer.
    Fraser RA; Ravry MJ; Segura JW; Go VL
    J Urol; 1975 Aug; 114(2):226-9. PubMed ID: 1159914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma.
    Mezger J; Lamerz R; Permanetter W
    J Thorac Cardiovasc Surg; 1990 Dec; 100(6):860-6. PubMed ID: 2147220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.